Myra Vision’s Post

Israeli Startup Raises $16 Million for Degenerative Disc Disease Treatment Discure Technologies, an Israeli startup, completed a $16 million round to advance its treatment for degenerative disc disease (DDD). The Series A round was led by BOLD Capital Partners, Supernova Invest, and Sanara Capital, with participation from U.S. hospital networks, orthopaedic surgeons, and MedTech investors. As the startup CEO Yuval Mandelbaum says, this investment will accelerate its growth, allowing it to make key hires and fully fund the First-in-Human clinical study in Canada and Italy. DDD accounts for 35% of all lower back pain. Whereas current treatments for DDD include opioids, injections and invasive surgery, Discure offers a disease-modifying solution. The funds will advance an implantable bioelectronic device designed to treat and reverse DDD by restoring fluids and nutrients to the affected discs. Source: https://lnkd.in/df7Uvrnd Photo: Yuval Mandelbaum

#fundingalert 💼Company: Protembis GmbH  💰Funding: €30 Million  ⚡Round: Series B 👥Investors:  Segulah Medical Acceleration, XGEN Venture SGR S.p.A., coparion, TechVision Fund. Protembis stands out as a notable player within the dynamic German startup ecosystem. This innovative heart surgery device (the ProtEmbo® Cerebral Protection System) is an intra-aortic filter device that protects the entire brain from embolic material liberated during transcatheter aortic valve replacement (TAVR). This round was use to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). It is a low-profile non thrombogenic system that shields all cerebral vessels, delivered through the left radial artery for optimal placement and stability. Karl von Mangoldt Conrad Rasmus Oliver Schumacher Nawzer Mehta James Hallums Read more - https://lnkd.in/gbHHt9nq To share your startup story write us on - contact@startuprise.co.uk #Protembis #healthtech #medtech #germanstartupecosystem #innovation #cardiovascular #heartdevice #funding #startupnews #fundingnews #news #germanstartup

Check out this Glaucoma Today article and see what Dr. Arsham Sheybani thinks of modulating aqueous flow with the Calibreye™ Titratable Glaucoma Therapy™ Surgical System.   https://lnkd.in/ef6bxKBx #glaucoma #IOP #innovation #startup #makingadifference

#fundingalert 💼Company: AVAVA 💰Funding: $35Million ⚡Round: New Round 👥Investors: Jeisys Medical, Catalio Capital Management. AVAVA™ developed a new class of FDA-cleared, non-invasive aesthetic medical devices with patented precision technology to provide best in class patient and provider experience for all skin tones. the company plans to use the funds to expedite the commercialization of its flagship product, MIRIA, a new class of aesthetic dermatology lasers that improves skin revitalization results for patients of all skin tones by precisely delivering energy to any location on the skin. Irina Erenburg, Frank Chiofalo, Bridget (Brewer) Horner, Dianna Ambrose Patrick MacAdie Read more -https://lnkd.in/gN6jJ9Z2 To share your startup story write us on - contact@startuprise.io #AVAVA #aestheticmedical #technology #dermatology #revitalization #commercialization #funding #fundingnews #new #startup #startupnews #startuprise

Our review of #orthopedic funding announcements in 1Q24 found familiar companies and well-backed markets like #spine, #robotics and #navigation received financial support. Medical Microinstruments, Inc. closed a Series C to support the commercialization of its robotic technology. Carlsmed closed a Series C to support the commercialization and further development of its personalized spine surgery platform. Synergy Spine Solutions raised equity financing to support clinical trials for its artificial disc. icotec raised growth financing to support the development of spine oncology implants. Accelus received a debt facility to accelerate growth of its expandable interbody fusion systems. Pixee Medical secured a capital raise to expand its presence in the U.S. and Asia Pacific. Bone Biologics completed an IPO to fund clinical trials and portfolio support. HAVENTURE startups raised funds to support the development of robotic technologies. Bolt Navigation closed a Series B to support commercialization efforts in the U.S. and EU. MotioOV received investments from OrthoVentions for its metatarsophalangeal joint implant. Check out the full recap. https://lnkd.in/eqr7mU_m #startups #funding #newtech

🌟 Important Medical Discovery 🌟 A recent study in JAMA Ophthalmology reveals a potential link between semaglutide and a rare eye condition, NAION, which can lead to blindness. The condition, called nonarteritic anterior ischemic optic neuropathy, can cause blindness. Stay informed about the latest research in ophthalmology! https://ow.ly/gO3I50SVovg #MedicalResearch #Ophthalmology #EyeHealth #MedicalDiscovery #SemaglutideResearch #NAIONAwareness #BlindnessPrevention #EyeHealthMatters #OphthalmologyNews #ResearchUpdate #HealthcareInnovation #MedicalScience #eyecbetter #fundraising #venturecapital

The Medical Aesthetic Injectable Summit (MAIS) invites physicians, academics, and industry professionals dedicated to aesthetic injectables on October 4 & 5, 2024. This event provides a platform for leaders to discuss the science, innovations, market trends, and business aspects of current and future toxins and dermal fillers. From clinician discussions on practice consensus to AI-powered speed matching for finding the right networking partners, MAIS is the first summit to bring together the entire microcosm of injectables. 📔 Check out the full program: https://lnkd.in/g9D4mzeJ 🐣 Register with Early Bird rates: https://lnkd.in/g-2GfP6h 👉 Interested in sponsoring? Find details here: https://lnkd.in/grD9__5n #mais2024 #summit #hyaluronicacid #toxins #fillers #injections #aesthetic #surgery #event #startups #business #research #science

We tracked 11 orthopedic company funding announcements in 2Q. The #startups will use the capital to conduct clinical trials and expand commercialization efforts across #orthopedics. The raises included: ▪ Integrity Orthopaedics - $20.6 million Series B ▪ Locate Bio Ltd - oversubscribed $11.5 million funding round ▪ Miach Orthopaedics, Inc. - $20 million Series B extension ▪ Nanochon - $4 million seed investment ▪ Osteal Therapeutics - oversubscribed $50 million Series D ▪ restor3d - $55 million Series A ▪ ReVivo Medical, Inc. - $1.3 million from current investors ▪ SLAM Orthopedic - $2.15 million seed investment ▪ SpinEM Robotics SAS - $11 million Series A2 ▪ Theradaptive - $1 million grant ▪ Viseon Inc. - insider financing round https://lnkd.in/eiSjpyKu #funding #medicaldevice

Sales surgery episode 49 is out! Why are so many VP Sales hires doomed to fail? We explain where it goes wrong and how to fix it. To see all our past episodes go to #pipesurgery #simonsays #pgtips #sales #technology #startups #strategy Pipe Global Robert Curtis

S Y N T H E T I C C O R N E A - incredible! - A revolutionary breakthrough in the field of ophthalmology! Offering new hope to millions with corneal blindness, this innovation replaces damaged corneas with synthetic ones. At 78, a man who lost his sight a decade ago can now see again thanks to artificial cornea implants. This transformative solution can potentially improve millions' lives globally by addressing previously irreversible blindness. 🔔 #wakeupimagine and follow Michael Chase and hit the bell icon on my page so you don’t miss future AI insights #FutureOfAi